OPKO Health Cash on Hand 2010-2024 | OPK

OPKO Health cash on hand from 2010 to 2024. Cash on hand can be defined as cash deposits at financial institutions that can immediately be withdrawn at any time, and investments maturing in one year or less that are highly liquid and therefore regarded as cash equivalents and reported with or near cash line items.
OPKO Health Annual Cash on Hand
(Millions of US $)
2023 $96
2022 $153
2021 $135
2020 $72
2019 $85
2018 $96
2017 $91
2016 $169
2015 $194
2014 $97
2013 $186
2012 $27
2011 $72
2010 $18
2009 $43
OPKO Health Quarterly Cash on Hand
(Millions of US $)
2024-03-31 $76
2023-12-31 $96
2023-09-30 $139
2023-06-30 $108
2023-03-31 $111
2022-12-31 $153
2022-09-30 $181
2022-06-30 $210
2022-03-31 $102
2021-12-31 $135
2021-09-30 $149
2021-06-30 $66
2021-03-31 $90
2020-12-31 $72
2020-09-30 $36
2020-06-30 $22
2020-03-31 $35
2019-12-31 $85
2019-09-30 $65
2019-06-30 $111
2019-03-31 $207
2018-12-31 $96
2018-09-30 $44
2018-06-30 $80
2018-03-31 $100
2017-12-31 $91
2017-09-30 $100
2017-06-30 $131
2017-03-31 $131
2016-12-31 $169
2016-09-30 $145
2016-06-30 $172
2016-03-31 $175
2015-12-31 $194
2015-09-30 $212
2015-06-30 $221
2015-03-31 $348
2014-12-31 $97
2014-09-30 $118
2014-06-30 $134
2014-03-31 $156
2013-12-31 $186
2013-09-30 $181
2013-06-30 $169
2013-03-31 $182
2012-12-31 $27
2012-09-30 $42
2012-06-30 $55
2012-03-31 $62
2011-12-31 $72
2011-09-30 $87
2011-06-30 $94
2011-03-31 $108
2010-12-31 $18
2010-09-30 $15
2010-06-30 $20
2010-03-31 $39
2009-12-31 $43
2009-09-30 $63
2009-06-30 $41
2009-03-31 $2
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $1.000B $0.864B
OPKO Health, Inc engages in the diagnostics and pharmaceuticals business in the United States, Ireland, Chile, Spain, Israel and Mexico. The Diagnostics segment operates Bio-Reference Laboratories, a clinical facility that offers testing services in the detection, diagnosis, evaluation, monitoring and treatment of diseases. The company's pharmaceutical business features Rayaldee, an FDA-approved treatment for secondary hyperparathyroidism (SHPT) in adults with stage 3 or 4 chronic kidney disease (CKD) and vitamin D insufficiency and VARUBI for chemotherapy induced nausea and vomiting. OPKO Health has a development and commercial supply pharmaceutical unit in Ireland along with a global supply chain operation and holding wing. The company also owns specialty active pharmaceutical ingredients (APIs) manufacturer in Israel.
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $210.799B 25.54
Intuitive Surgical (ISRG) United States $161.707B 91.56
Edwards Lifesciences (EW) United States $52.456B 34.14
Alcon (ALC) Switzerland $44.851B 32.13
DexCom (DXCM) United States $44.592B 67.55
IQVIA Holdings (IQV) United States $43.531B 24.67
IDEXX Laboratories (IDXX) United States $38.850B 45.54
STERIS (STE) Ireland $22.904B 26.75
Hologic (HOLX) United States $18.227B 20.39
Waters (WAT) United States $17.845B 26.23
SONOVA HOLDING (SONVY) Switzerland $17.827B 0.00
Fresenius Medical Care AG KGaA (FMS) Germany $11.654B 13.60
Teleflex (TFX) United States $10.521B 16.38
Sysmex ADR (SSMXY) Japan $10.076B 31.60
Globus Medical (GMED) United States $9.934B 29.12
Penumbra (PEN) United States $7.299B 82.95
Glaukos (GKOS) United States $6.310B 0.00
Masimo (MASI) United States $5.831B 33.53
TransMedics (TMDX) United States $5.118B 485.56
Integer Holdings (ITGR) United States $4.224B 25.52
PROCEPT BioRobotics (PRCT) United States $3.569B 0.00
Inari Medical (NARI) United States $3.182B 0.00
LivaNova (LIVN) United Kingdom $2.956B 17.55
Tandem Diabetes Care (TNDM) United States $2.840B 0.00
Integra LifeSciences Holdings (IART) United States $2.472B 10.78
Veracyte (VCYT) United States $1.797B 0.00
RxSight (RXST) United States $1.793B 0.00
Alphatec Holdings (ATEC) United States $1.542B 0.00
Artivion (AORT) United States $1.163B 111.56
Pulse Biosciences (PLSE) United States $1.068B 0.00
Silk Road Medical (SILK) United States $1.067B 0.00
AVANOS MEDICAL, INC (AVNS) United States $1.042B 20.27
OrthoPediatrics (KIDS) United States $0.802B 0.00
Paragon 28 (FNA) United States $0.708B 0.00
SiBone (SIBN) United States $0.703B 0.00
Mesa Laboratories (MLAB) United States $0.614B 18.16
ORTHOFIX MEDICAL INC (OFIX) United States $0.611B 0.00
IRadimed (IRMD) United States $0.601B 33.67
Pacific Biosciences Of California (PACB) United States $0.504B 0.00
Treace Medical Concepts (TMCI) United States $0.499B 0.00
AxoGen (AXGN) United States $0.413B 0.00
Sight Sciences (SGHT) United States $0.410B 0.00
Nevro (NVRO) United States $0.361B 0.00
Tactile Systems Technology (TCMD) United States $0.307B 10.52
AngioDynamics (ANGO) United States $0.300B 0.00
NeuroPace (NPCE) United States $0.243B 0.00
Delcath Systems (DCTH) United States $0.241B 0.00
Semler Scientific (SMLR) United States $0.240B 12.19
Inogen (INGN) United States $0.227B 0.00
CVRx (CVRX) United States $0.214B 0.00
ClearPoint Neuro (CLPT) United States $0.211B 0.00
Accuray (ARAY) United States $0.201B 0.00
908 Devices (MASS) United States $0.192B 0.00
Atossa Genetics (ATOS) United States $0.186B 0.00
EDAP TMS S.A (EDAP) France $0.171B 0.00
Alpha Tau Medical (DRTS) Israel $0.146B 0.00
KORU Medical Systems (KRMD) United States $0.119B 0.00
Spectral Diagnostics (EDTXF) Canada $0.106B 0.00
Sensus Healthcare (SRTS) United States $0.105B 22.14
Monogram Orthopaedics (MGRM) United States $0.086B 0.00
Hyperfine (HYPR) United States $0.085B 0.00
EnVVeno Medical (NVNO) United States $0.076B 0.00
InspireMD (NSPR) Israel $0.061B 0.00
LENSAR (LNSR) United States $0.061B 0.00
Neuronetics (STIM) United States $0.057B 0.00
Lucid Diagnostics (LUCD) United States $0.046B 0.00
Envoy Medical (COCH) United States $0.045B 0.00
T2 Biosystems (TTOO) United States $0.044B 0.00
Vicarious Surgical (RBOT) United States $0.042B 0.00
Precision Optics (POCI) United States $0.039B 0.00
DarioHealth (DRIO) United States $0.037B 0.00
ReWalk Robotics (LFWD) Israel $0.033B 0.00
Spectral AI (MDAI) United States $0.031B 0.00
Accelerate Diagnostics (AXDX) United States $0.028B 0.00
Rapid Micro Biosystems (RPID) United States $0.028B 0.00
Ekso Bionics Holdings (EKSO) United States $0.024B 0.00
Autonomix Medical (AMIX) United States $0.022B 0.00
Pixie Dust Technologies (PXDT) Japan $0.021B 0.00
Aspira Women's Health (AWH) United States $0.021B 0.00
Microbot Medical (MBOT) United States $0.017B 0.00
NexGel (NXGL) United States $0.017B 0.00
QT Imaging Holdings (QTI) United States $0.015B 0.00
Inspira Technologies OXY B.H.N (IINN) Israel $0.014B 0.00
Check-Cap (CHEK) Israel $0.012B 0.00
PAVmed (PAVM) United States $0.010B 0.00
ENDRA Life Sciences (NDRA) United States $0.006B 0.00
Venus Concept (VERO) Canada $0.004B 0.00
SINTX TECHNOLOGIES, INC (SINT) United States $0.003B 0.00
Avinger (AVGR) United States $0.003B 0.00
ReShape Lifesciences (RSLS) United States $0.003B 0.00
Helius Medical Technologies (HSDT) United States $0.003B 0.00
Tenon Medical (TNON) United States $0.002B 0.00
Nuwellis (NUWE) United States $0.002B 0.00
Nanovibronix (NAOV) United States $0.002B 0.00
Bluejay Diagnostics (BJDX) United States $0.000B 0.00
Longview Acquisition II (LGV) United States $0.000B 0.00
Spinal Elements Holdings (SPEL) United States $0.000B 0.00